Board Changes

Aortech International PLC
13 May 2005

For Immediate Release                                               13 May 2005


                           AorTech International plc
                          ('AorTech' or the 'Company')

                                 Board Changes

AorTech International plc (AIM:AOR), the biomaterials Intellectual Property and
Material Manufacturing Company today announces changes to its Board as a
consequence of restructuring of the business.

Laurie Rostron, Chairman, and Peter Gibson, Non-Executive Director of the
Company have stepped down and Jon Pither has assumed the role of Chairman. The
Board also announces the appointment of Dr Stuart Rollason as a Non-Executive
Director.

The Board is of the view that the family of Elast-Eon(TM) polymer biomaterials is
being successfully developed to the point where its potential is increasingly
being recognised as the material of choice for an array of long-term, high
fatigue, blood contacting medical device applications.

Good progress has also been made with the internal development of high
value-added platforms for Elast-Eon(TM), particularly with next generation 
breast implant and heart valve products. It is anticipated that opportunities 
for these markets will be exploited through licensing opportunities with its 
partners, or alternative means of investment.

Jon Pither, who has considerable experience of managing such opportunities, has
been appointed to oversee the development of these initiatives, for the full
exploitation of these technology assets.

It is intended that Union Investment Management Ltd (which has a relationship
with one of the Company's shareholders) will also be engaged to assist the Board
with this project.

Commenting on the restructuring, Jon Pither, Chairman said:

'Elast-Eon(TM) has reached a stage where large established companies in the
biomaterials market should find it attractive to commercialise the successful
development advances that have been achieved.'

For further information please contact:

AorTech International plc
Frank Maguire, Chief Executive                   07766 543 649/ 00 1801 201 4336

Buchanan Communications                                            020 7466 5000
Ben Willey, Lisa Baderoon, Rebecca Skye Dietrich



Visit AorTech's website at: www.aortech.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange